Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
Project Number5U01DK135095-03
Contact PI/Project LeaderKULKARNI, ROHIT N. Other PIs
Awardee OrganizationJOSLIN DIABETES CENTER
Description
Abstract Text
PROJECT SUMMARY
Type 1 diabetes and its metabolic consequences continue to be among the most significant biomedical
challenges in the US and worldwide today. In addition to morbidities specifically related to diabetes the disease
is associated with complications such as renal failure, lipid disorders, cardiovascular disease and cancer and is
a major cause of death worldwide. Thus there is an urgent need for a better understanding of the pathogenesis
that promotes the loss of insulin-secreting beta cells to plan better therapeutics to combat the disease. Several
studies have argued that diverse cell types that make up the pancreatic niche contribute to the pathogenesis of
the disease process. Thus a better understanding of the inter-cellular communication between major cells such
as the acinar and duct cells and islet cells are warranted. We have studied the role of the mutant carboxy ester
lipase (CEL) gene, expressed in acinar cells, on its ability to be taken up by beta cells and cause defects in its
function and growth. The goal of this proposal is to discover the changes that occur when secretome from acinar
versus duct cells are incubated with human islet and β-cells. The data from these studies will generate new
hypothesis for testing that will allow a deeper interrogation of the cross-talk between human acinar, duct and
islet cells. We will address the following Aims in this proposal: Aim 1) Determine the ability of human acinar
versus human duct cells to directly impact islet cell function. We will isolate and characterize EVs, from human
induced pluripotent stem (hIPS) cell derived acinar- versus duct-lineage committed organoids, and incubate
them with human islet/β-cells and human pancreas slices to directly examine the consequences on islet cell
biology. We will also examine the EV cargo with a particular focus on fragments derived from transfer RNAs.
Aim 2) We will interrogate the ability of EVs, derived from acinar-derived organoids generated from the hiPS
cells from MODY8 patients, to directly regulate human islet-β-cell biology. The use of human organoids and
human pancreas slices will provide translational relevance of our studies. The results and datasets obtained
from these experiments will complement the efforts of the Human Islet Research Network and provide novel
resources to be shared with the larger scientific community.
Public Health Relevance Statement
PROJECT NARRATIVE
This proposal is aimed at exploring the cross talk between the exocrine and endocrine cells of the pancreas. The
focus is centered on understanding the intercellular communication between key players in the pancreatic niche
that can directly impact the function of islet cells. The long-term objective is to use the information obtained from
the experiments in these studies to gain a higher resolution understanding of the mechanisms that underlie the
pathogenesis of type 1 diabetes.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
071723084
UEI
UUUMQVGJNNX1
Project Start Date
20-September-2022
Project End Date
30-June-2026
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$904,104
Direct Costs
$795,230
Indirect Costs
$108,874
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$904,104
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01DK135095-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01DK135095-03
Patents
No Patents information available for 5U01DK135095-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01DK135095-03
Clinical Studies
No Clinical Studies information available for 5U01DK135095-03
News and More
Related News Releases
No news release information available for 5U01DK135095-03
History
No Historical information available for 5U01DK135095-03
Similar Projects
No Similar Projects information available for 5U01DK135095-03